STP-702

N/A

Report date: 2022/12/27 17:34:14
NME

Base Information

Drug NameSTP-702
Drug Alias NameSTP-702
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferencePolymerase acidic protein inhibitorsMatrix protein 1 inhibitors
TargetsPolymerase acidic proteinMatrix protein 1
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWalvax Biotechnology Co LtdSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A